Catch-up vaccination against Haemophilus influenzae type b in human immunodeficiency virus-infected Thai children older than 2 years old

Vaccine

Volumn 22, Issue 15-16, 2004, Pages 2018-2022

  Chokephaibulkit, Kulkanya ^a   Phongsamart, Wanatpreeya ^a   Vanprapar, Nirun ^a   Chotpitayasunondh, Tawee ^b   Chearskul, Sanay ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b QUEEN SIRIKIT NATIONAL INSTITUTE OF CHILD HEALTH   (Thailand)

Author keywords

Antibody response; Haemophilus vaccination; HIV infected children

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; TETANUS TOXOID;

ARTICLE; CLINICAL TRIAL; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; GEOMETRY; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; INFLUENZA; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROCONVERSION; THAILAND; VACCINATION; VIRUS LOAD; VIRUS TITRATION;

ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; TETANUS; THAILAND; VACCINATION; VACCINES, CONJUGATE; VIRAL LOAD;

EID: 2342644906     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.10.033     Document Type: Article

References (22)

1. WHO. Global program for vaccine and immunization (GPV). Wky Epidemiol Rec 1998;73:64-71.
2. CDC. Progress toward eliminating Haemophilus influenzae type b disease among infants and children - United States, 1987-1997. MMWR 1998;47:993-8.
3. Singleton R., Bulkow L.R., Levine O.S., Butler J.C., Hennessy T.W., Parkinson A. Experience with the prevention of invasive Haemophilus influenzae type b disease by vaccination in Alaska: the impact of persistent oropharyngeal carriage. J. Pediatr. 137:2000;313-320
4. Lolekha S. A review of Hib epidemiology in Asia. Southeast Asian J. Trop Med. Public Health. 31:2000;650-657
5. Rorks-Ngam S, Kunasol P, Chunsultiwat S. Incidence of Haemophilus influenzae type b meningitis in two provinces of Thailand 2000-2001. In: 10th International Congress on Infectious Diseases, Singapore, 10-14 March 2002, vol. abstract number 18002.
6. Sunakorn P. Current situation of Haemophilus influenzae b disease in Thailand. Com. Dis. J. 22:1996;301-307
7. Lolekha S, Prevalence of immunity against Haemophilus influenzae type b in Thai infants and children. In: 36th Thai Congress of Pediatrics, vol. 23; 1993. p. 53-5 (Abstract).
8. Booy R., Heath P.T., Slack M.P., Begg N., Moxon E.R. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster. Lancet. 349:1997;1197-1202
9. Farley M.M., Stephens D.S., Brachman P.S. Jr., Harvey R.C., Smith J.D., Wenger J.D. Invasive Haemophilus influenzae disease in adults. A prospective, population-based surveillance. CDC Meningitis Surveillance Group. Ann. Intern. Med. 116:1992;806-812
10. Steinhart R., Reingold A.L., Taylor F., Anderson G., Wenger J.D. Invasive Haemophilus influenzae infections in men with HIV infection. JAMA. 268:1992;3350-3352
11. Casadevall A., Dobroszycki J., Small C., Pirofski L.A. Haemophilus influenzae type b bacteremia in adults with AIDS and at risk for AIDS. Am. J. Med. 92:1992;587-590
12. Kale K.L., King J.C. Jr., Farley J.J., Vink P.E., Cimino C.O., Paradiso P.R. The immunogenicity of Haemophilus influenzae type b conjugate (HbOC) vaccine in human immunodeficiency virus-infected and uninfected infants. Pediatr. Infect. Dis. J. 14:1995;350-354
13. Madhi S.A., Petersen K., Khoosal M., Huebner R.E., Mbelle N., Mothupi R., et al. Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection. Pediatr. Infect. Dis. J. 21:2002;315-321
14. Wernette C.M., Frasch C.E., Madore D., Carlone G., Goldblatt D., Plikaytis B., et al. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin. Diagn. Lab. Immunol. 10:2003;514-519
15. Plikaytis B., Turner S., Gheesling L., Carlone G. Comparisons of standard curve-fitting methods to quantitate Neisseria meningitides group A polysaccharide antibody levels by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 29:1991;1439-1446
16. Kayhty H., Peltola H., Karanko V., Makela P.H. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J. Infect. Dis. 147:1983;1100
17. CDC. Revised classification system for human immunodeficiency virus infection in children less than 13 year of age. MMWR 1994;43:1-19.
18. Gibb D., Giacomelli A., Masters J., Spoulou V., Ruga E., Griffitns H., et al. Persistence of antibody responses to Haemophilus influenzae type b polysaccharide conjugate vaccine in children with vertically acquired human immunodeficiency virus infection. Pediatr. Infect. Dis. J. 15:1996;1097-1101
19. Peters V.B., Sood S.K. Immunity to Haemophilus influenzae type b polysaccharide capsule in children with human immunodeficiency virus infection immunized with a single dose of Haemophilus vaccine. J. Pediatr. 125:1994;74-77
20. Granoff D.M., Anderson E.L., Osterholm M.T., Holmes S.J., McHugh J.E., Belshe R.B., et al. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. J. Pediatr. 121:1992;187-194
21. Holmes S.J., Murphy T.V., Anderson R.S., Kaplan S.L., Rothstein E.P., Gan V.N., et al. Immunogenicity of four Haemophilus influenzae type b conjugate vaccines in 17- to 19-month-old children. J. Pediatr. 118:1991;364-371
22. Chub-uppakarn S. Immunogenicity of Haemophilus influenzae type b conjugate vaccines PRP-OMP in children at Hat Yai Hospital. J. Infect. Dis. Antimicrob. Agents. 17:2000;55-58